Trends In China’s Medical Device Imports
This article was originally published in PharmAsia News
Executive Summary
China's import of medical devices saw a 16.3 percent increase in 2007 after shrinking the previous year. U.S., Germany and Japan, the top three sources, accounted for nearly 70 percent of the total business. The U.S. is the largest supplier with its electronic medical treatment products, while Germany shows the strongest growth potential. A number of trends can be observed: a significant increase in digital product import; a rise in price and volume of medical implants and consumables; MNCs maintaining their technological advantage; Beijing, Shanghai and Guangdong forming the major importers; and China's reliance on imported sophisticated equipment. Analysts expect medical device import to maintain moderate growth for this year. (Click here for more - Chinese Language)
You may also be interested in...
California Bill To Age-Restrict Sales Of Diet Pills Further Along Than Other States’ Legislation
CA, MA and NJ legislatures remain in session with bills active proposing regulations similar to NY law effective 22 April requiring retailers, including online, to ask for proof of age when customers buying consumer health products containing ingredients labeled or promoted for weight loss and bodybuilding benefits appear younger than 18.
CRN Has Standing For Steep Hill To Climb Challenging New York's Age-Restricted Sales
Federal judge finds “misreading of the legislation” in CRN’s argument that state “restricts access based purely on what has been said about the product or its ingredients.” But standing to challenge “means that only CRN is positioned right now to go before the court on behalf of industry,” says CEO Steve Mister.
Addition to Quest Alzheimer's Suite Looks For Biomarker P-Tau217
The test is being integrated into Quest’s AD-Detect portfolio for assessing the risk of Alzheimer’s. It is the third p-tau217 test to make news this month, after new breakthrough designations for Quanterix and Roche and Eli Lilly.